Eresearchtechnology Inc /DE/ - Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0287 Expires: January 31, 2008 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940

1. Name and Address of Reporting Person * LAKY DAVID J	2. Issuer Name and Ticker or Trading Symbol ERESEARCHTECHNOLOGY INC /DE/ [ ERES ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director                      _____ 10% Owner __ X __ Officer (give title below)      _____ Other (specify below) Sr. V.P., eClinical
(Last)          (First)          (Middle) C/O ERESEARCHTECHNOLOGY, INC., 30 SOUTH 17TH STREET	3. Date of Earliest Transaction (MM/DD/YYYY) 2/28/2008
(Street) PHILADELPHIA, PA 19103 (City)        (State)        (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _ X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option (Right to Buy)	$12.00	2/28/2008		A		20000		(1)	2/28/2015	Common Stock, $.01 par value	20000	$12.00	20000	D
Option (Right to Buy)	$8.52							(1)	5/7/2014	Common Stock, $.01 par value	10000		10000	D
Option (Right to Buy)	$3.01							(2)	7/23/2012	Common Stock, $.01 par value	8437		8437	D
Option (Right to Buy)	$6.29							(2)	4/22/2013	Common Stock, $.01 par value	16875		16875	D
Option (Right to Buy)	$22.09							(2)	2/9/2014	Common Stock, $.01 par value	9001		9001	D
Option (Right to Buy)	$15.46							(1)	2/14/2012	Common Stock, $.01 par value	6000		6000	D
Option (Right to Buy)	$14.70							(1)	2/10/2013	Common Stock, $.01 par value	5000		5000	D
Option (Right to Buy)	$7.41							(1)	2/23/2014	Common Stock, $.01 par value	5000		5000	D

Explanation of Responses:
( 1)	Options become exercisable in four equal annual installments beginning one year after date of grant and are fully exercisable three years prior to expiration.
( 2)	Options are fully exercisable.

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
LAKY DAVID J C/O ERESEARCHTECHNOLOGY, INC. 30 SOUTH 17TH STREET PHILADELPHIA, PA 19103			Sr. V.P., eClinical

Signatures
David Laky		2/29/2008
** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.